Completed

Phase 3
Age: 50Years +
All Genders
ID00000167

Complications of Age-Related Macular Degeneration Prevention Trial (CAPT)

Led by National Eye Institute (NEI) · Updated on 2010-03-24

1052

Participants Needed

24

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

To determine whether application of low-intensity laser treatment of eyes with drusen in the macula can prevent later complications of age-related macular degeneration and thereby preserve visual function.

CONDITIONS

Brief Title

Complications of Age-Related Macular Degeneration Prevention Trial

Who Can Participate

Age: 50Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

Patients eligible for CAPT can be either male or female and meet the following criteria:

Age at least 50 years old

Vision in each eye must measure 20/40 or better.

At least 10 large drusen in each eye

Available for follow-up examinations for 5 years after enrollment

Final eligibility is determined through a detailed eye examination by a CAPT-certified ophthalmologist.

Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Total: 24 locations

1

Retinal Consultants of Arizona, Ltd.

Mesa, Arizona, United States, 85201

Status Unknown

2

Retinal Consultants of Arizona, Ltd.

Peoria, Arizona, United States, 85351

Status Unknown

3

West Coast Retina Medical Group, Inc.

San Francisco, California, United States, 94107

Status Unknown

4

University of South Florida Eye Institute

Tampa, Florida, United States, 33612-4766

Status Unknown

5

Emory Eye Center

Atlanta, Georgia, United States, 30322

Status Unknown

6

Northwestern University

Chicago, Illinois, United States, 60611

Status Unknown

7

Illinois Retina Associates, S.C.

Harvey, Illinois, United States, 60426

Status Unknown

8

University of Iowa

Iowa City, Iowa, United States, 55242-1091

Status Unknown

9

Ophthalmology & Visual Sciences at the University of Louisville, School of Medicine

Louisville, Kentucky, United States, 40202-1594

Status Unknown

10

The Johns Hopkins University

Baltimore, Maryland, United States, 21287-9223

Status Unknown

11

Ophthalmic Consultants of Boston

Boston, Massachusetts, United States, 02114

Status Unknown

12

Associate Retinal Consultants, P.C.

Royal Oak, Michigan, United States, 48073

Status Unknown

13

Mayo Clinic

Rochester, Minnesota, United States, 55905

Status Unknown

14

Barnes Retina Institute

St Louis, Missouri, United States, 63110

Status Unknown

15

Retina-Vitreous Center, P.A.

Edison, New Jersey, United States, 08820

Status Unknown

16

Retina-Vitreous Center, P.A.

Lakewood, New Jersey, United States, 08701

Status Unknown

17

Southeast Clinical Research Associates

Charlotte, North Carolina, United States, 28204

Status Unknown

18

Retina Associates of Cleveland

Cleveland, Ohio, United States, 44122

Status Unknown

19

The Ohio State University, Department of Ophthalmology

Columbus, Ohio, United States, 43210

Status Unknown

20

Casey Eye Institute

Portland, Oregon, United States, 97201-4197

Status Unknown

21

Retina Northwest, P.C.

Portland, Oregon, United States, 97210

Status Unknown

22

Scheie Eye Institute

Philadelphia, Pennsylvania, United States, 19104

Status Unknown

23

Texas Retina Associates

Dallas, Texas, United States, 75231

Status Unknown

24

University of Wisconsin - Madison, Department of Ophthalmology and Visual Sciences

Madison, Wisconsin, United States, 53705

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Similar Trials

A Randomized Double-masked, Multicenter, 3-arm, Pivotal Phas...

Macular Degeneration

Actively Recruiting

30 locations

A Randomized, Double-Masked, Multicenter Study Comparing the...

Macular Degeneration

Actively Recruiting

9 locations

Randomized, Double-blind Study Comparing Ranibizumab 10mg/ml...

Diabetic Macular Edema

Actively Recruiting

1 location

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial